CLINICAL_TRIALS
trial_result
· 2014-10-29
Clinical Trial Update: A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia [Phase 3]
Summary
The document reports that a Phase 3 trial evaluating YM443 (Z-338) for functional dyspepsia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Dyspepsia, Functional Dyspepsia | Phase 3 | Status: COMPLETED